LARVOL Onco Data Podcast

🎙️ LARVOL ONCO DATA Podcast: Pre-ASCO Insights with Mark Gramling and Judith Pérez Join us for an episode of LARVOL ONCO DATA Podcast as we delve into pre-American Society of Clinical Oncology (ASCO) insights. Our hosts, Mark Gramling and Judith Perez, share their perspectives on the upcoming ASCO conference. 🌐 Previewing ASCO: Get a sneak peek into the advancements, trends, and hot topics in oncology as we prepare for the upcoming ASCO conference, one of the largest gatherings of oncology professionals worldwide. 🔍 Preparation Strategies: Discover how LARVOL is gearing up for ASCO, and learn about strategies and tools to maximize the conference experience. Join us for an episode that provides insights into the oncology landscape. Tune in to LARVOL ONCO DATA Podcast for an informative discussion.

🎙️ LARVOL ONCO DATA Podcast: Pre-ASCO Insights with Mark Gramling, Linh Nguyen, Sugata Biswas, and Zachary Moore Get ready for another episode of LARVOL ONCO DATA Podcast as we dive into pre-American Society of Clinical Oncology (ASCO) insights. Join our hosts, Mark Gramling and Linh Nguyen, along with guests Sugata Biswas, Founder at Cadence Communications & Research, and Zachary Moore, for a dynamic discussion. 🌐 Previewing ASCO: Explore the advancements, trends, and topics in oncology as we preview the upcoming ASCO conference, one of the largest gatherings of oncology professionals worldwide. 💡 Expert Perspectives: Gain insights from our panelists as they share their expertise, offering unique perspectives and analysis. Join us for an engaging episode that provides insights into the oncology landscape. #LARVOL #ASCO #ESOPEC #ISPY #MONARCH #POSTMONARCH

LARVOL Onco Data Podcast! In this episode, we are thrilled to have Darko Medin, an expert in biostatistics and data analysis, join us for an insightful discussion on Network Meta-Analysis (NMA).

Network Meta-Analysis is a powerful tool that combines data from multiple studies to compare different treatments for the same condition. Darko Medin will break down the fundamentals of NMA, explain its significance in oncology research, and discuss how it helps in making informed clinical decisions.
Whether you're a healthcare professional, researcher, or just interested in the latest in oncology data analysis, this episode provides valuable insights into the world of Network Meta-Analysis. 

🎙️ LARVOL ONCO DATA Podcast: AACR Insights with Mark Gramling, Judith Perez, and Erin Olsen from Bluestarbio Advisors Join us for an episode of LARVOL ONCO DATA Podcast as we unpack the latest developments from the American Association for Cancer Research (AACR) conference. Our hosts, Mark Gramling and Judith Perez from LARVOL, along with Erin from Bluestarbio Advisors, share their perspectives and insights. 🌐 Reflecting on AACR: Dive into the highlights and key takeaways from AACR, one of the most significant events in the field of cancer research. 💡 Expert Analysis: Gain valuable insights from our panelists as they analyze the latest research findings, trends, and advancements presented at AACR. 🔍 Real-World Applications: Discover how these insights from AACR are shaping the future of oncology research and clinical practice, with a focus on practical applications and implications. Join us for an episode that delves into the post-AACR landscape. Tune in to LARVOL ONCO DATA Podcast for an engaging discussion. Checkout Bluestarbio Advisor on this link: https://lnkd.in/gBz-pMKb

🎙️ LARVOL ONCO DATA Podcast: Insights from AACR Tune in to the latest episode of LARVOL ONCO DATA Podcast, where hosts Mark Gramling and Bruno Larvol bring you discussions centered around the American Association for Cancer Research (AACR) conference. 🌐 Exploring AACR: Delve into the highlights and key findings from the AACR conference, a pivotal event in the field of cancer research. 💡 Expert Analysis: Gain valuable insights from Mark and Bruno as they analyze the latest advancements and breakthroughs presented at AACR. 🔍 Practical Applications: Discover how these insights from AACR are shaping the future of cancer research and treatment, with a focus on real-world applications. Join us for an engaging episode that unpacks the latest developments.

In this episode of Larvol Onca Data Podcast, we sit down with Matt Lewis, a leading expert in AI voice technology, to explore the fascinating world of artificial intelligence voices. Matt shares his insights on the latest advancements, the impact of AI voices on various industries, and what the future holds for this rapidly evolving technology. Tune in to hear about the challenges and opportunities in developing realistic and expressive AI voices, and how they are transforming communication, entertainment, and beyond.

#Podcast #AIVoice #Technology #MattLewis #ArtificialIntelligence #Innovation #FutureTech #Larvol #Oncology

Join us for an in-depth exploration of how real-world evidence (RWE) is transforming oncology research and regulatory decision-making. This video delves into the importance of patient-reported outcomes (PROs) in understanding the true impact of cancer treatments on patients' lives. Learn from leading experts about the current regulatory landscape, key challenges, and future directions for integrating RWE and PROs in oncology. Don't miss this essential discussion for healthcare professionals, researchers, and policymakers!

#Oncology #RealWorldEvidence #PatientReportedOutcomes #Healthcare #RegulatoryScience #CancerResearch

Join hosts Mark Gramling and Bruno Larvol as they navigate through the complexities of hazard ratio, a cornerstone statistic in oncology studies. Hazard ratio serves as a powerful tool for assessing the relative risk of an event occurring between two groups, such as patients receiving different treatments or exposed to varying risk factors.

In this enlightening discussion, we explore how hazard ratio influences decision-making in cancer research and treatment. From its interpretation in survival analysis to its implications for treatment efficacy and patient outcomes, we'll uncover the profound impact of hazard ratio on shaping the landscape of oncology.

With insights from leading experts and real-world examples from recent studies and clinical trials, this episode provides a comprehensive understanding of hazard ratio and its significance in advancing our knowledge of cancer.

Whether you're a healthcare professional, researcher, or simply passionate about staying informed on the latest developments in oncology, this episode promises to deepen your understanding of hazard ratio and its role in improving patient care.

🎙️ LARVOL ONCO DATA Podcast: Insights from ASCO GU with LARVOL CLIN Join us for an episode of LARVOL ONCO DATA Podcast as we delve into insights from the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), with a spotlight on LARVOL CLIN. Our hosts, Mark Gramling and Bruno Larvol, along with guest Judith Pérez, Director of Data Science, share valuable takeaways. Recapping ASCO GU: Explore the highlights and key learnings from ASCO GU, a significant event in the field of genitourinary oncology. LARVOL CLIN's Role: Learn about the impact of LARVOL CLIN at ASCO GU and its role in providing data insights for genitourinary cancer research. Practical Applications: Discover how LARVOL is applying insights gained from ASCO GU, using LARVOL CLIN to offer practical solutions for oncology professionals. Join us for an engaging episode that recaps ASCO GU and discusses the real-world applications of LARVOL CLIN in genitourinary cancer research. Tune in to LARVOL ONCO DATA Podcast for an informative conversation.

Join us for another episode of LARVOL ONCO DATA Podcast as we reflect on the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) with a focus on LARVOL CLIN. Our hosts, Mark Gramling and Bruno Larvol, along with Judith Pérez, Associate Director of Data Science, share insights. 🌐 Recapping ASCO GI: Dive into the highlights and explore key takeaways. 💡 LARVOL CLIN Impact: Actionable insights for the oncology community. 🔍 Gain insights into how LARVOL is applying the lessons learned from ASCO GI & bringing real-world value to oncology professionals. Join us for an episode that showcases the practical implications of LARVOL CLIN in oncology research. Tune in to LARVOL ONCO DATA Podcast for a meaningful conversation.